EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Mechanism of Action of Melatonin as a Potential Adjuvant Therapy in Inflammatory Bowel Disease and Colorectal Cancer

Abdo Jurjus, Jad El Masri, Maya Ghazi, Lemir Majed El Ayoubi, Lara Soueid, Alice Gerges Geagea, Rosalyn Jurjus

Nutrients · 21.04.2024 · 16 (8) · 1236

DOI: 10.3390/nu16081236 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 21.04.2024. Verfasst von Abdo Jurjus und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy, Cell Biology and Physiological Sciences, Faculty of Medicine, American University of Beirut, Beirut 1107, Lebanon. Hauptthemen laut MEDLINE: Melatonin, Colorectal Neoplasms, Inflammatory Bowel Diseases, Gastrointestinal Microbiome. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 185 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory bowel disease (IBD), a continuum of chronic inflammatory diseases, is tightly associated with immune system dysregulation and dysbiosis, leading to inflammation in the gastrointestinal tract (GIT) and multiple extraintestinal manifestations. The pathogenesis of IBD is not completely elucidated. However, it is associated with an increased risk of colorectal cancer (CRC), which is one of the most common gastrointestinal malignancies. In both IBD and CRC, a complex interplay occurs between the immune system and gut microbiota (GM), leading to the alteration in GM composition. Melatonin, a neuroendocrine hormone, was found to be involved with this interplay, especially since it is present in high amounts in the gut, leading to some protective effects. Actually, melatonin enhances the integrity of the intestinal mucosal barrier, regulates the immune response, alleviates inflammation, and attenuates oxidative stress. Thereby, the authors summarize the multifactorial interaction of melatonin with IBD and with CRC, focusing on new findings related to the mechanisms of action of this hormone, in addition to its documented positive outcomes on the treatment of these two pathologies and possible future perspectives to use melatonin as an adjuvant therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelatoninColorectal NeoplasmsInflammatory Bowel DiseasesGastrointestinal MicrobiomeHumansIntestinal MucosaOxidative StressAnimalsDysbiosis

Stichwörter der Autor:innen

colorectal cancerimmune systeminflammationinflammatory bowel diseasemelatoninoxidative stress

Substanzen

Melatonin

Autor:innen und Institutionen

  • Department of Anatomy, Cell Biology and Physiological Sciences, Faculty of Medicine, American University of Beirut, Beirut 1107, Lebanon.
  • Faculty of Medical Sciences, Lebanese University, Beirut 6573, Lebanon.

Zitieren

APA

Jurjus, A., El Masri, J., Ghazi, M., El Ayoubi, L. M., Soueid, L., Gerges Geagea, A., & Jurjus, R. (2024). Mechanism of Action of Melatonin as a Potential Adjuvant Therapy in Inflammatory Bowel Disease and Colorectal Cancer. Nutrients, 16(8), 1236. https://doi.org/10.3390/nu16081236

Vancouver

Jurjus A, El Masri J, Ghazi M, El Ayoubi LM, Soueid L, Gerges Geagea A, et al. Mechanism of Action of Melatonin as a Potential Adjuvant Therapy in Inflammatory Bowel Disease and Colorectal Cancer. Nutrients. 2024;16(8):1236. doi:10.3390/nu16081236

BibTeX
@article{Jurjus2024,
  author = {Jurjus, Abdo and El Masri, Jad and Ghazi, Maya and El Ayoubi, Lemir Majed and Soueid, Lara and Gerges Geagea, Alice and Jurjus, Rosalyn},
  title = {Mechanism of Action of Melatonin as a Potential Adjuvant Therapy in Inflammatory Bowel Disease and Colorectal Cancer},
  journal = {Nutrients},
  year = {2024},
  volume = {16},
  number = {8},
  pages = {1236},
  doi = {10.3390/nu16081236}
}
Kostenlos starten →